Category:
Active Pharmaceutical Ingredients
CAS NO:
390800-88-1
Standard:
In-house Standards,
Bortezomib is a proteasome inhibitor used in oncology. Synthesized via peptide coupling, its molecular formula is C16H24BN3O6P (CAS: 179324-69-7).
Store at -20°C. Handle with PPE due to cytotoxicity. Contraindicated in severe hypersensitivity or pregnancy.